First patient treated in U.S.-approved embryonic stem cell trial
The first patient to be treated in a U.S.-government-approved study involving human embryonic stem cells has been injected with millions of the potentially life saving cells.
The patient, being cared for at the Shepherd Center in Atlanta, is partially paralyzed following a spinal cord injury. The center specializes in treating these types of injuries.
According to the trial's protocol, patients must receive the stem cell injection within 14 days of the injury. The trial only involves patients with spinal cord injuries.
- 1 in 5 Eligible Hospitals Penalized for HACs
- 'Mega Boards' Could be Rural Healthcare Disruptor
- Two-Midnight Rule Will Cost Hospitals Big
- The Hospital of the Future is Not a Hospital
- Meaningful Use Payment Adjustments Begin
- PA hospital to pay $662,000 to settle Medicare fraud case
- HL20: Rebecca Katz—Cooking Up Sustainable Nourishment
- Supreme Court to hear Obamacare subsidy challenge in March
- HL20: Peter Semczuk, DDS, MPH—Taking on the Big Challenges
- 12 Hires to Keep Your Hospital Out of Trouble